Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer

Area of Science:

• Oncology
• Genomics
• Translational Medicine

Background:

• Precision medicine has transformed cancer care, yet its application in ovarian cancer is hindered by significant biological complexity.
• Ovarian cancer's diverse tumor biology and heterogeneity complicate genetic profiling and the identification of treatment response biomarkers.

Purpose of the Study:

• To review the multifaceted barriers impeding the implementation of precision medicine in ovarian cancer.
• To explore ethical, socio-economic, and logistical challenges associated with precision oncology in this disease.

Main Methods:

• Literature review and synthesis of current research on precision medicine in ovarian cancer.
• Analysis of challenges in tissue acquisition, assay development, data infrastructure, and ethical considerations.

Main Results:

• Key barriers include obtaining adequate tissue, standardizing screening assays, and managing complex data infrastructure.
• Ethical issues concerning patient consent, data privacy, and health equity require careful navigation.

Conclusions:

• Addressing socio-economic factors, enhancing patient and professional education, and developing supportive regulatory frameworks are vital.
• Interdisciplinary collaboration is essential for advancing precision medicine and improving ovarian cancer patient care and outcomes.